Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma Registry.

[1]  A. Gesierich,et al.  Completion Dissection or Observation for Sentinel‐Node Metastasis in Melanoma , 2017, The New England journal of medicine.

[2]  C. Berking,et al.  Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. , 2016, The Lancet. Oncology.

[3]  B. Bastian,et al.  From melanocytes to melanomas , 2016, Nature Reviews Cancer.

[4]  Nam Huh,et al.  Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination , 2015, Proceedings of the National Academy of Sciences.

[5]  R. Elashoff,et al.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma. , 2014, The New England journal of medicine.

[6]  A. Luini,et al.  Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. , 2013, The Lancet. Oncology.

[7]  V. Sondak,et al.  A brief history of melanoma: from mummies to mutations , 2012, Melanoma research.

[8]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[9]  John S. Condeelis,et al.  Chemotaxis in cancer , 2011, Nature Reviews Cancer.

[10]  B. Fisher,et al.  The breast cancer alternative hypothesis: is there evidence to justify replacing it? , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  D. Coit,et al.  Outcome of Patients with a Positive Sentinel Lymph Node who do not Undergo Completion Lymphadenectomy , 2010, Annals of Surgical Oncology.

[12]  C. Klein,et al.  Parallel progression of primary tumours and metastases , 2009, Nature Reviews Cancer.

[13]  B. Cady,et al.  Role of Lymphadenectomy in Surgical Treatment of Solid Tumors: An Update on the Clinical Data , 2007, Annals of Surgical Oncology.

[14]  H. Gutman,et al.  Melanoma Patients with Positive Sentinel Nodes Who Did Not Undergo Completion Lymphadenectomy: A Multi-Institutional Study , 2006, Annals of Surgical Oncology.

[15]  R. Hynes,et al.  Lymphatic or Hematogenous Dissemination: How Does a Metastatic Tumor Cell Decide? , 2006, Cell cycle.

[16]  T. Yamano,et al.  CCL21 Chemokine Regulates Chemokine Receptor CCR7 Bearing Malignant Melanoma Cells , 2004, Clinical Cancer Research.

[17]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[18]  John F. Thompson,et al.  Patterns of lymphatic drainage from the skin in patients with melanoma. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  Jong-Hyeon Jeong,et al.  Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. , 2002, The New England journal of medicine.

[20]  Peter Carmeliet,et al.  Molecular mechanisms of lymphangiogenesis in health and disease. , 2002, Cancer cell.

[21]  H. Wiley,et al.  Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. , 2001, Journal of the National Cancer Institute.

[22]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  N. Cascinelli,et al.  Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial , 1998, The Lancet.

[24]  M. Mihm,et al.  Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. , 1996, Annals of surgery.

[25]  C. Garbe,et al.  Primary cutaneous melanoma. Prognostic classification of anatomic location , 1995, Cancer.

[26]  R. Clark,et al.  Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. , 1991, American journal of surgery.

[27]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[28]  C. Balch.  The role of elective lymph node dissection in melanoma: rationale, results, and controversies. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  B. Cady,et al.  Lymph node metastases. Indicators, but not governors of survival. , 1984, Archives of surgery.

[30]  B. Fisher.  Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture. , 1980, Cancer research.

[31]  F. Sim,et al.  A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results , 1978, Cancer.

[32]  N. Cascinelli,et al.  Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. , 1977, The New England journal of medicine.

[33]  Sugarbaker Ev,et al.  Melanoma of the trunk: the results of surgical excision and anatomic guidelines for predicting nodal metastasis. , 1976 .

[34]  E. Sugarbaker,et al.  Melanoma of the trunk: the results of surgical excision and anatomic guidelines for predicting nodal metastasis. , 1976, Surgery.

[35]  A. Constanti,et al.  Letter: Central inhibition, G.A.B.A., and tutin. , 1974, Lancet.

[36]  B. Fisher,et al.  Transmigration of Lymph Nodes by Tumor Cells , 1966, Science.

[37]  W. Halsted.  I. The Results of Radical Operations for the Cure of Carcinoma of the Breast. , 1907, Annals of surgery.